AMBS communication about Lympro launch in Q4 has not changed all year, Enrollment is done, icon is on board. It will happen. Even if it did get so called 'delayed' it would be Jan latest. Highly doubt that though. People focus way too hard on milestones here and if it doesn't hit the exact month then it's Armageddon. Ridiculous. This is biotech.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links